Head to Head Contrast: Bonk (BNKK) vs. Its Rivals

Bonk (NASDAQ:BNKK) is one of 343 public companies in the “Financial Services” industry, but how does it compare to its rivals? We will compare Bonk to similar companies based on the strength of its valuation, profitability, dividends, analyst recommendations, risk, institutional ownership and earnings.

Insider and Institutional Ownership

12.6% of Bonk shares are owned by institutional investors. Comparatively, 43.2% of shares of all “Financial Services” companies are owned by institutional investors. 51.6% of Bonk shares are owned by company insiders. Comparatively, 22.0% of shares of all “Financial Services” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares Bonk and its rivals top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Bonk	$2.12 million	-$68.19 million	-0.36
Bonk Competitors	$6.33 billion	$1.08 billion	9.07

Bonk’s rivals have higher revenue and earnings than Bonk. Bonk is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Risk & Volatility

Bonk has a beta of 2.04, meaning that its stock price is 104% more volatile than the S&P 500. Comparatively, Bonk’s rivals have a beta of 2.27, meaning that their average stock price is 127% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current recommendations for Bonk and its rivals, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bonk	1	0	0	0	1.00
Bonk Competitors	1895	6728	11416	414	2.51

As a group, “Financial Services” companies have a potential upside of 3.20%. Given Bonk’s rivals stronger consensus rating and higher probable upside, analysts plainly believe Bonk has less favorable growth aspects than its rivals.

Profitability

This table compares Bonk and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Bonk	-952.21%	-137.47%	-122.67%
Bonk Competitors	-407.42%	-21.88%	-5.62%

Summary

Bonk rivals beat Bonk on 12 of the 13 factors compared.

About Bonk

Safety Shot, Inc., a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc. and changed its name to Safety Shot, Inc. in September 2023. The company was incorporated in 2018 and is headquartered in Jupiter, Florida.